Abstract
Soft tissue sarcomas (STS) are rare malignancies, accounting for 1% of all tumors. The most common site of origin is the extremities (50%), followed by the retroperitoneum (20%), the viscera (15%), the superficial trunk (10%) and the head and neck (5%). Local recurrence is more common among low-grade tumors, while high-grade STS tend to spread distantly. Optimal surgery, with en-bloc resection and clear margins is the only potential curative treatment of localized STS, but it should be tailored to the specific histology and be part of a multidisciplinary management of the disease. A multidisciplinary approach is the goal in all cases of STS. Treatment strategies for all patients must be the result of the consensus of the multidisciplinary team including surgical oncologists, pathologists, radiologists, radiation therapists, and medical oncologists. Given the complexity of the disease and the heterogeneity of the various presentations, it is necessary that the management of sarcoma patients is centralized to referral centers and/or within reference networks that share multidisciplinary expertise. These centers should treat a high number of patients annually and be involved in ongoing clinical trials that allow for the best tailored treatment for each specific case.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Casali PG, Abecassis N, Bauer S, et al. Soft tissue and visceral sarcomas: ESMO–EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv51–67.
Gundle KR, Kafchinski L, Gupta S, et al. Analysis of margin classification systems for assessing the risk of local recurrence after soft tissue sarcoma resection. J Clin Oncol. 2018;36(7):704–9.
Gronchi A, Casali PG, Mariani L, et al. Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. J Clin Oncol. 2005;23(1):96–104.
Gronchi A, Lo Vullo S, Colombo C, et al. Extremity soft tissue sarcoma in a series of patients treated at a single institution. The local control directly impacts survival. Ann Surg. 2010;251(3):506–11.
Gronchi A, Verderio P, De Paoli A, et al. Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall. Ann Oncol. 2013;24(3):817–23.
Dingley B, Fiore M, Gronchi A. Personalizing surgical margins in retroperitoneal sarcomas: an update. Expert Rev Anticancer Ther. 2019;19(7):613–31.
Antritsch E, Beishon M, Bielack S, et al. ECCO essential requirements for quality cancer care: soft tissue sarcoma in adults and bone sarcoma. A critical review. Crit Rev Oncol Hematol. 2017;110:94–105.
Bonvalot S, Gronchi A, Le Pechoux C, et al. STRASS (EORTC 62092): a phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma. J Clin Oncol. 2019;37(15 Suppl):11001. https://doi.org/10.1200/JCO.2019.37.15_suppl.11001.
Derbel O, Heudel PE, Cropet C, et al. Survival impact of centralization and clinical guidelines for soft tissue sarcoma (a prospective and exhaustive population-based cohort). PLoS One. 2017;12(2):e0158406. https://doi.org/10.1371/journal.pone.0158406.
Blay JY, Honoré C, Stoeckle E, et al. Surgery in reference centers improves survival of sarcoma patients: a nationwide study. Ann Oncol. 2019;30(7):1143–53.
Blay JY, Bonvalot S, Gouin F, et al. Criteria for reference centers for sarcomas: volume but also long-term multidisciplinary organisation. Ann Oncol. 2019;30(12):2008–9.
Kalaiselvan R, Malik AK, Rao R, et al. Impact of centralization of services on outcomes in a rare tumour: retroperitoneal sarcomas. Eur J Surg Oncol. 2019;45(2):249–53.
Bonvalot S, Gaignard E, Stoeckle E, et al. Survival benefit of the surgical management of retroperitoneal sarcoma in a reference center: a nationwide study of the French Sarcoma Group from the NetSarc database. Ann Surg Oncol. 2019;26(7):2286–93.
Villano AM, Zeymo A, McDermott J, et al. Regionalization of retroperitoneal sarcoma surgery to high-volume hospitals: missed opportunities for outcome improvement. J Oncol Pract. 2019;15(3):e247–61.
Keung EZ, Chiang YJ, Cormier JN, et al. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer. 2018;124(23):4495–503.
Villano AM, Zeymo A, Chan KS, et al. Identifying the minimum volume threshold for retroperitoneal soft tissue sarcoma resection: merging national data with consensus expert opinion. J Am Coll Surg. 2020;230(1):151–60.e2.
Raut CP, Bonvalot S, Gronchi A. A call to action: why sarcoma surgery needs to be centralized. Cancer. 2018;124(23):4452–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Spolverato, G., Quagliuolo, V., Gronchi, A. (2021). Volume-Outcome Relationship in Surgery of Soft Tissue Sarcomas. In: Montorsi, M. (eds) Volume-Outcome Relationship in Oncological Surgery. Updates in Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-51806-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-51806-6_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-51805-9
Online ISBN: 978-3-030-51806-6
eBook Packages: MedicineMedicine (R0)